Item 2. Unregistered Sales of Equity Securities
Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Issuer Purchases of Equity Securities
The following table provides information about The Cigna Group's share repurchase activity for the quarter ended June 30, 2024:
Period Total # of shares purchased (1)
Average price paid per share (1)
Total # of shares purchased as part of
publicly announced program (2)
Approximate dollar value of shares
that may yet be purchased as part
of publicly announced program (3) (in millions)
April 1-30, 2024 300 $ 367.11 — $ 7,284
May 1-31, 2024 2,863,087 (1) 2,860,996 $ 6,900
June 1-30, 2024 1,807,858 $ 339.33 1,806,656 $ 6,293
Total 4,671,245 (1) 4,667,652 N/A
(1) Includes shares tendered by employees under the Company's equity compensation plans as follows: 1) payment of taxes on vesting of restricted stock (grants and units) and strategic performance shares and 2) payment of the exercise price and taxes for certain stock options exercised. Employees tendered 300 shares in April, 2,091 shares in May and 1,202 shares in June 2024. Amount purchased in May 2024 also reflects the final settlement of approximately 1.7 million shares for no additional consideration pursuant to the ASR agreements discussed in the Liquidity and Capital Resources section of Management's Discussion and Analysis of Financial Condition and Results of Operations in Part 1, Item 2. For shares not purchased pursuant to the accelerated share repurchase agreements, the average price paid per share for the period May 1 to May 31, 2024 was $337.95 and for the quarter ended June 30, 2024 was $338.79.
(2) Additionally, the Company maintains a share repurchase program authorized by the Board. Under this program, the Company may repurchase shares from time to time, depending on market conditions and alternate uses of capital. The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions and alternate uses of capital. The share repurchase program may be effected through Rule 10b5-1 plans, open market purchases, each in compliance with Rule 10b-18 under the Exchange Act, or privately negotiated transactions. The program may be suspended or discontinued at any time and does not have an expiration date.
(3) Approximate dollar value of shares is as of the last date of the applicable month and excludes the impact of excise tax.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.